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a  b  s  t  r  a  c  t
The  elevated  T-maze  (ETM)  is  an  apparatus  derived  from  the  elevated  plus-maze  test,  which  is used  to
evaluate  anxiety.  Because  anxiety  is  a biasing  factor  in  models  of  memory,  this  study  proposed  the ETM  as
a  task  for the  simultaneous  assessment  of  memory  and  anxiety  in  mice.  The  ETM  consists  of one  enclosed
and  two open  arms.  The  procedure  is based  on  the  avoidance  of open  spaces  learned  during  training
session,  in  which  mice  were  exposed  to  the  enclosed  arm  as  many  times  as  needed  to  stay  300  s. In the
test  session,  memory  is  assessed  by re-exposing  the  mouse  to the  enclosed  arm  and  the  latency  to enter  an
open  arm  was  recorded.  The  anxiolytic  diazepam  (DZP;  1  or 2 mg/kg)  and  the  amnestic  biperiden  (BPR;
0.5, 1 or  3  mg/kg)  were  injected  at  three  distinct  times:  pre-training,  post-training,  and  pre-test.  Pre-
training  administration  of  BPR  1  and DZP  2  increased  the  number  of  trials  needed  to  reach  the avoidance
criterion,  suggesting  a passive  avoidance  learning  impairment.  However,  BPR  induced  hyperlocomotion,
which  could  bias  the  interpretation  of  any  BPR-induced  effects  during  the  training  session.  Pre-training
injection  of  BPR  did  not  affect  the  spontaneous  increase  in the  latency  to enter  an  open  arm  between  trials,
while DZP  reduced  latencies  in  the  ﬁrst  three  trials  suggesting  anxiolysis.  In  the  test  session,  pre-training
injection  of  BPR  1 and DZP  2  reduced  latencies  to  enter  an  open  arm,  indicating  memory  impairment.
Post-training  and  pre-test  injection  of DZP  or  BPR  did  not  affect  memory.  In  conclusion,  the  proposed
ETM  task  is practical  for  the  detection  of  the  anxiolytic  and  amnesic  effects  of  drugs.. Introduction
Learning is an indispensable step in memory retention; how-
ver, it is a process affected by individual basal states, such as
motion, attention, motivation and perception. In fact, emotional
tates, such as fear and aversion, can modulate, by enhancing or
mpairing, memory formation [22]. Because the available animal
odels of learning and memory have a limited ability to detect the
ffects of drugs on anxiety and fear, memory, as measured by these
odels, could be misinterpreted. Therefore, the proposed elevated
-maze (ETM) task is an attempt to assess the effects of drugs on
nxiety, learning and memory concomitantly in mice.
The ETM is an apparatus derived from the elevated plus-maze,
hich is widely used to evaluate anxiety levels based on an etho-
ogical view of rodents [6].  The ETM consists of one enclosed and
wo open arms, and in the most common protocol, the latency
Abbreviations: ETM, elevated T-maze; BPR, biperiden; DZP, diazepam.
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to leave the enclosed and open arms is recorded during consec-
utive trials. Experiments performed in rats have showed that the
ETM is a validated model of anxiety because anxiolytic agents
such as diazepam (benzodiazepine), buspirone, ipsapirone (5-HT1A
agonists) and ritanserin (5-HT2 antagonist) selectively impair the
latency to leave the enclosed arm in the ﬁrst three consecutive trials
[15]. Other pharmacological studies, showing that chronic treat-
ment with antidepressants, such as imipramine and escitalopram,
reduced the latency to leave the enclosed arm (impaired inhibitory
avoidance) and support the view that this behavioral parameter in
the ETM may  be related to generalized anxiety disorder [24,30].
To simultaneously investigate the effects of anxiety and mem-
ory, Graeff et al. [14] proposed an animal model based on the ETM.
In this study, an experimental protocol was validated by testing
the effects of distinct doses of diazepam, an anxiolytic drug with
amnestic effects. These authors found that during the test session,
diazepam abolished the delay of leaving the enclosed arm toward
the open arms, measured soon after training and 72 h later. This
result suggests that diazepam affected the memory process in rats.
Soon after this ﬁrst study, Prof. Graeff’s research group tested the
Open access under the Elsevier OA license.effects of anxiolytic drugs, such as diazepam and ipsapirone, an
azapirone anxiolytic that is devoid of clinically signiﬁcant amnestic
effects. They found that both drugs impaired inhibitory avoidance,
which could be interpreted as an anxiolytic effect. However, when
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e-exposed 3 days later to the ETM, the latency to leave the enclosed
rm was reduced only in diazepam-treated rats, indicating antero-
rade amnesia [32].
One critical question raised by these initial ETM ﬁndings was
hether the anterograde amnesia induced by anxiolytic drugs
ould be due to insufﬁcient learning during training or to amne-
ia. Thus, a new study proposed an alteration in the experimental
rotocol, which included the introduction of a multi-trial training-
o-criterion procedure [8].  In this study, during the training session,
ats were tested as many times as necessary for them to stay in
he enclosed arm continuously for 300 s. The effects of diazepam
n this pre-training treatment protocol were also tested, and the
esults indicated that diazepam dose-dependently impaired mem-
ry retention [8].  The amnestic drug scopolamine was also tested
n rats via the ETM task [10]. The authors reported that at the
ower dose (0.3 mg/kg), scopolamine impaired memory retention;
owever, at the higher dose (1.2 mg/kg), it disrupted learning and
emory process in the ETM task.
Aside from the limited number of studies, recent reports
mployed the ETM task as an animal model of memory in rats
9,21,28]. However, to our knowledge, only one study used the ETM
ask, by following the same protocol as reported for rats, to test
earning and memory processes in mice [29]. In this interesting
tudy, despite being focused on memory effects of the cannabinoid
eceptor blockade, the authors showed that scopolamine evokes
mnestic effects, which were reversed by the CB1 receptor antago-
ist SR141716A.
Therefore, considering the lack of information in the literature
egarding the validation of the ETM task in the assessment of learn-
ng, memory and anxiety simultaneously in mice, the present study
imed to investigate the effects of two standard drugs: diazepam
an anxiolytic drug with amnestic effects) and biperiden (a selective
1 muscarinic receptor antagonist which evokes amnestic effects)
t three distinct times: pre-training, post-training, and before the
est session, to propose the ETM as a putative model of anxiety
nd memory in mice. Additionally, the effects of these drugs on
ocomotor activity were also tested in the open ﬁeld test.
. Materials and methods
.1. Animals
Male Swiss mice weighing 25–30 g were housed in groups of ten to twelve per
age (33 cm × 40 cm × 17 cm) in an enriched environment with food and water pro-
ided ad libitum. Animals were maintained under constant temperature (23 ± 2 ◦C)
nd  under a 12-h light/dark cycle (lights on at 06:00). Behavioral studies were
pproved by the local Ethics Committee in the Use of Animals in Federal University
f Rio Grande do Norte (Protocol No. 040/2009) and strictly followed the Brazilian
aw No. 11.794/2008 for the care and use of experimental animals.
.2. Drugs and treatment
The drugs used were diazepam, a benzodiazepine receptor site agonist (Cristália
harmaceutical Laboratories, Brazil) and biperiden, a muscarinic M1 receptor antag-
nist (Cristália Pharmaceutical Laboratories, Brazil). Biperiden was dissolved in
aline (0.9% NaCl), while diazepam was  solubilized in saline plus 2% Tween-80.
iazepam (1 or 2 mg/kg, intraperitoneal, i.p.) and biperiden (0.5, 1 or 3 mg/kg, sub-
utaneous, s.c.) were administered to separate experimental groups at three distinct
imes: (1) 30 min  before the training session, (2) immediately after the training ses-
ion, and (3) 30 min  before the test session in a volume of 10 ml/kg body weight.
he  doses of biperiden used in the current study were based on Kimura et al. [17].
aline and saline plus 2% Tween-80 were injected into control mice.
.3. Behavioral tests
.3.1. Elevated T-maze (ETM) task
In this study, the ETM was  used to assess learning and memory features in mice.he  experimental protocol was based on the report of Conde et al. [8]. The ETM was
ade of wood and had three arms of equal dimensions (30 cm × 6 cm). One arm,
nclosed by walls 16 cm high, was perpendicular to two  opposing arms. A Plexiglas
order 0.5 cm high surrounded the open arms. The whole apparatus was elevated
0  cm above the ﬂoor. On the training day, each mouse was  placed at the distal endlletin 87 (2012) 526– 533 527
of the enclosed arm facing the intersection of the arms and was allowed to explore
the  enclosed arm. The trial ended when the mouse entered one of the open arms
by  placing all four paws into the open arm or remained in the enclosed arm for a
maximum of 300 s. In the training session, which was performed only on one day,
mice were re-exposed to the ETM as many times as needed to remain in the enclosed
arm  for 300 s (avoidance criterion). The number of trials to reach the avoidance
criterion was  used to assess learning. The time in which the animal remained in
the  enclosed arm was recorded for each trial (avoidance latency). Importantly, the
ﬁrst three trials of the training session (i.e., trial 1, trial 2 and trial 3) were used to
estimate the anxiety levels experienced by animals. A 30 s inter-trial interval was
adopted and, following this, animals were returned to their home cages. Twenty-
four hours (and, depending on the protocol, 48 or 96 h) after training (test session),
mice were re-exposed to the enclosed arm during two  subsequent trials (i.e., test
and retest). The time that the animal remained in the enclosed arm was recorded
and used to assess memory retrieval. Experiments were performed in a dimly lit and
quiet room with an observer inside the room (3 m × 3 m) seated at least 2 m from
the open arms of the apparatus. All experiments were performed between 13:00
and 17:00. The apparatus was cleaned with 5% ethanol solution between subjects.
2.3.2. Open ﬁeld test
Locomotor activity of mice was measured using the open ﬁeld test. During the
test,  animals were allowed to freely explore the apparatus for 15 min. The apparatus,
made of wood covered with impermeable formica, had a black ﬂoor of 60 cm ×60 cm
and white 60-cm high walls. The test room had a controlled illumination (dimly
lit  condition). Each mouse was placed in the center of the open ﬁeld and the dis-
tance traveled every 5 min  was recorded through automatic observation (Any-maze,
Stoelting, USA) for 15 min. Locomotion was recorded between 13:00 and 17:00. After
the behavioral evaluation of each mouse, the apparatus was cleaned with 5% ethanol
solution.
2.4. Experimental design
2.4.1. Experiment 1
This series of experiments was performed to assess the time-course of the avoid-
ance behavior displayed by mice toward the open arms in the test session of the ETM
task. Distinct groups of mice were subjected to the training session of the ETM task,
and  24, 48 or 96 h after that session, mice were re-exposed to the apparatus, and
latency to enter an open arm with all four paws was  assessed. To estimate the long
term duration of the open arm avoidance behavior in the ETM, the same animals
that were trained in the apparatus and tested 48 h after training were re-exposed
to  the ETM test 15 days after training.
2.4.2. Experiment 2
To assess the effects of standard drugs on learning and memory processes,
mice were randomly assigned to different treatment groups and were given an
intraperitoneal injection of diazepam (1.0 and 2.0 mg/kg), a subcutaneous injec-
tion of biperiden (0.5 and 1.0 mg/kg) or vehicle (i.p. or s.c.). Thirty minutes after
drug  injection, each mouse was  submitted to the ETM training session. Twenty-four
hours after training, mice were again subjected to the enclosed arm of the ETM, and
the latency to enter an open arm was recorded.
2.4.3. Experiment 3
To evaluate the effect of biperiden (1 and 3 mg/kg), diazepam (2 mg/kg) or vehi-
cle  on memory consolidation, mice were randomly assigned to different treatment
groups, and drug administration was given immediately after the ETM training ses-
sion. The biperiden half-life is approximately 22 h, so in an attempt to rule out any
possible hyper-locomotor effect of biperiden (at 3 mg/kg) in the ETM test session
for  this dose, the interval between training and the test session was 48 h.
2.4.4. Experiment 4
To investigate of the effects of standard drugs on memory retrieval, mice were
randomly assigned to different treatment groups and were given an intraperitoneal
injection of diazepam (1.0 and 2.0 mg/kg), a subcutaneous injection of biperiden
(1.0 mg/kg) or vehicle (i.p. or s.c.) 30 min before the ETM test session.
2.4.5. Experiment 5
To investigate the effects of diazepam (1.0 and 2.0 mg/kg; administered
intraperitoneally), biperiden (0.5 and 1.0 mg/kg; subcutaneously injected) or vehicle
(i.p. or s.c.) on spontaneous locomotor activity, 30 min after treatment, mice were
placed on the open ﬁeld and they were allowed to explore the apparatus individually
during a period of 15 min, as previously described.
2.5. Statistics
The data presented herein were reported as the means ± S.E.M. All results
were initially submitted to Levene’s test for homogeneity of variance and to
Kolmogorov–Sminorv’s test of normality. Comparisons between the ﬁrst three con-
secutive trials during the training session were analyzed by repeated measures
ANOVA. Comparisons between the treated and control groups were performed using
one-way ANOVA followed by Dunnett’s test or t-test, when necessary. A value of
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Fig. 1. Latencies to enter an open arm of the ETM with all four paws in the ﬁrst th
erformed 24, 48 or 96 h after training session (B). The animals did not receive any t
P  < 0.05, #P = 0.07.
 < 0.05 was  considered to be signiﬁcant. These analyses were performed using SPSS
oftware, version 16.0.
. Results
.1. Experiment 1
Repeated measures ANOVA showed that in non-treated mice
xposed to the ETM apparatus during training session, the latency
o enter one of the open arms with all four paws increased
pontaneously within the ﬁrst three trials (Fig. 1A; 24 h: P = 0.07,
(2,12) = 3.14; 48 h: P = 0.07, F(2,16) = 1.82; 96 h: P = 0.03, F(2,12) = 4.71).
his suggests the acquisition of inhibitory avoidance toward the
pen arms.
To determine if mice remembered the ETM task, we  compared
he latencies of the ﬁrst trial in the training session (i.e., the ani-
als’ baseline), and the ﬁrst trial in the test session. A paired t-test
ndicated that, independent of the time since prior exposure to the
TM task 24, 48 or 96 h before the test session, animals displayed
igher retention latencies in the enclosed arm during the test ses-
ion compared to the ﬁrst trial of the training session (24 h: P = 0.03,
(6) = 3.21; 48 h: P = 0.01, t(8) = 4.63; 96 h: P = 0.02, t(6) = 5.15). In fact,
5 days after training, mice still remembered the task. t-Tests found
hat there was a signiﬁcant difference between the ﬁrst trial of the
raining session and the ﬁrst trial of the test session, which took
lace 15 days later (1st trial training session: 39.2 ± 9.8 s; 1st trial
est session: 300 ± 0.0 seg; n = 9; P < 0.001, t(8) = 11.17).
.2. Experiment 2
One-way ANOVA followed by Dunnett’s post hoc test showed
hat, at a dose of 1 mg/kg, but not 0.5 mg/kg, biperiden, mice
equired an increased number of trials to reach the avoidance crite-
ion (Fig. 2A; P = 0.002; F(2,29) = 7.89), thus suggesting impairment
f their learning processes. One-way ANOVA followed by Dun-
ett’s post hoc test found that mice treated with diazepam (1 and
 mg/kg) required an increased number of trials to reach the crite-
ion of remaining on the enclosed arm for 300 s, but this increase
id not reach statistical signiﬁcance (Fig. 2B; P = 0.09; F(2,21) = 2.58).
While still in the training session, one-way ANOVA showed
hat the administration of biperiden did not result in a differ-
nce in the latency to enter an open arm between the ﬁrst three
onsecutive trials compared to the control group (Fig. 2C; trial 1:
 > 0.05, F(2,29) = 2.12; trial 2: P > 0.05, F(2,29) = 1.23; trial 3: P > 0.05,
(2,29) = 1.51). However, one-way ANOVA followed by Dunnett’snsecutive trials during the training session (A), and in the test session, which was
ent. Each bar represents mean ± S.E.M. of 6–8 animals. Repeated measures ANOVA;
post hoc test indicated that the administration of 1 or 2 mg/kg
diazepam signiﬁcantly reduced the latency to enter an open arm
during trial 1 (Fig. 2D; P = 0.01; F(2,21) = 5.71), trial 2 (Fig. 2D;
P = 0.005; F(2,21) = 6.94), and trial 3 (Fig. 2D; P = 0.006; F(2,21) = 6.73).
Taken together, these results suggest that the ETM task is able to
detect anxiolytic-like effects of diazepam in mice.
During the test session, the latency to enter an open arm
in the ETM was decreased following treatment with 1 mg/kg
biperiden during the ﬁrst and the second trials (Fig. 2E;
P = 0.001; F(2,29) = 23.34, and P = 0.016; F(2,29) = 4.77, respectively)
or 2 mg/kg diazepam (Fig. 2F; P = 0.02; F(2,21) = 4.53, and P < 0.001;
F(2,21) = 12.10, respectively) compared to controls. Interestingly, the
administration of 1 mg/kg diazepam did not affect this parameter
in the test session (Fig. 2F). These ﬁndings suggest that the ETM
task can detect the impairment of memory induced by 1 mg/kg
biperiden and 2 mg/kg diazepam.
3.3. Experiment 3
Mice administered 2 mg/kg diazepam and 1 and 3 mg/kg biperi-
den immediately after training were also evaluated in the ETM task
(Fig. 3 and Table 1). t-Tests found that 1 and 3 mg/kg biperiden
(Fig. 3A and B; BPR 1: P > 0.05, t(17) = 0.80; BPR 3: P > 0.05, t(12) = 1.24)
or 2 mg/kg diazepam (Fig. 3C; P > 0.05; t(12) = 0.68) did not affect the
ﬁrst latency to enter an open arm of the ETM during the test session.
This indicates that the post-training administration of diazepam or
biperiden did not affect memory consolidation during the test ses-
sions. Importantly, the control, diazepam- and biperiden-treated
mice during the training session (in which animals were not under
the effect of drugs) did not differ in the number of trials required
to reach the avoidance criterion, or in the latency to enter an open
arm of the ETM in the ﬁrst three consecutive trials (Table 1).
3.4. Experiment 4
In the training sessions, when animals were not under the effect
of drugs, no signiﬁcant differences were found between the groups
for any analyzed parameters (Table 1; P > 0.05). When injected
30 min  before the test session, t-tests indicated that biperiden
(1 mg/kg) did not affect the latency to enter an open arm of the
ETM compared to controls (Fig. 4A; P > 0.05; t(13) = 0.12). One-way
ANOVA showed that diazepam (1 or 2 mg/kg) was also not able
to affect the latency to enter an ETM open arm compared to con-
trols (Fig. 4B; P > 0.05; F(2,20) = 0.64). These ﬁndings suggest that
biperiden and diazepam do not disturb memory retrieval.
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Fig. 2. Effects of pre-training administration of biperiden and diazepam in mice submitted to the ETM task. Number of trials required to learn the avoidance criterion, which
was  met  when mice stayed in the enclosed arm for 300 s (A and B). Latencies to enter an open arm of the ETM with all four paws in the ﬁrst three consecutive trials (C and D).
Latencies to enter an open arm of the ETM with all four paws in the test session (E and F). Training began 30 min  after biperiden or diazepam injection. Each bar represents
the  mean ± S.E.M. of 7–12 animals. ANOVA, Dunnett’s test, *P < 0.05 compared to controls. BPR 0.5: biperiden 0.5 mg/kg, BPR 1: biperiden 1 mg/kg, DZP 1: diazepam 1 mg/kg,
DZP  2: diazepam 2 mg/kg.
Table 1
Latencies to enter one of the open arms of the ETM with all four paws in the ﬁrst three consecutive trials (i.e., trial 1, trial 2 and trial 3) and the number of trials to reach the
avoidance criterion during training session in mice treated with diazepam (DZP) and biperiden (BPR) immediately after training and before test session.
Treatment Trial 1 Trial 2 Trial 3 Number of trials
Posttraining
Control 79.7 ± 25.3 110.7 ± 30.8 169.8 ± 42.6 5.3 ± 0.8
DZP  2 48.6 ± 7.5 65.3 ± 15.7 59.9 ± 16.5 6.6 ± 1.0
Control  48.0 ± 23.4 97.0 ± 49.9 156.8 ± 82.7 5.8 ± 1.9
BPR  1 73.3 ± 14.1 88.2 ± 12.6 154.0 ± 27.9 5.0 ± 0.5
Control  51.3 ± 20.5 50.9 ± 18.2 84.1 ± 22.0 6.6 ± 0.6
BPR  3 46.0 ± 15.0 57.3 ± 23.5 103.3 ± 42.0 5.3 ± 0.8
Pretest
Control  74.4 ± 25.8 61.7 ± 14.5 89.9 ± 32.6 6.1 ± 0.5
DZP  1 71.4 ± 28.0 91.1 ± 29.2 111.3 ± 36.2 4.6 ± 0.6
DZP  2 63.1 ± 13.3 52.7 ± 18.1 164.0 ± 43.0 5.1 ± 0.8
BPR 88.5 ± 15.0 67.9 ± 8.4 136.6 ± 38.1 5.6 ± 0.7
Data are shown as the mean ± S.E.M. (7–10 mice/group).
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Fig. 3. Effects of post-training administration of 1 mg/kg (A) or 3 mg/kg (B) biperiden or 2 mg/kg diazepam (C) to mice submitted to the ETM task. Latencies to enter an
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Epen  arm of the ETM with all four paws in the test session. Test session was perfo
 mg/kg biperiden. The animals were treated immediately after the training session
:  biperiden 3 mg/kg, DZP 2: diazepam 2 mg/kg.
.5. Experiment 5
In a separate set of experiments, the effects of biperiden (0.5
nd 1 mg/kg), diazepam (1 and 2 mg/kg) and vehicle on spon-
aneous locomotor activity were tested in the open ﬁeld test.
ne-way ANOVA showed that the administration of 1 mg/kg, but
ot 0.5 mg/kg, biperiden, caused a signiﬁcant increase in the cumu-
ative distance traveled by mice during 15 min  of observation in
he open ﬁeld test (Fig. 5A; P = 0.024; F(2,23) = 4.41). When we aver-
ged the distance moved in 5-min time blocks, we observed an
ncrease in this parameter in mice treated with 1 mg/kg biperi-
en at 5 and 10 min  of observation (Fig. 5B; ANOVA, Dunnett’s
est; 5 min: P = 0.04, F(2,23) = 3.69; 10 min: P = 0.01 F(2,23) = 4.87). At
ll doses tested, diazepam did not affect locomotor activity, com-
ared to controls (Fig. 5C and D; ANOVA, Dunnett’s test; P > 0.05,
(2,18) = 1.42).
. Discussion
The focus of this study was to validate the ETM task as a putative
nimal model for the assessment of anxiety, learning and memory
imultaneously in mice. This model has been reported on previ-
usly in a series of studies which tested the effects of diazepam
nd scopolamine on the behavior of rats [8,10] using the experi-
ental protocol reported by Conde et al. In this version of the ETM,
ig. 4. Effects of pre-test administration of 1 mg/kg biperiden (A) or 1 and 2 mg/kg diazep
f  the ETM with all four paws in the test session. Each test session was  performed 24 h a
ach  bar represents the mean ± S.E.M. of 7–10 animals. BPR 1: biperiden 1 mg/kg, DZP 1:  24 h after training for diazepam and 1 mg/kg biperiden, and 48 after training for
 bar represents the mean ± S.E.M. of 7–10 animals. BPR 1: biperiden 1 mg/kg, BPR
the authors proposed exposure of the rats to the enclosed arm in the
training session as many times as needed to reach the avoidance cri-
terion, which was met  when the animal stayed in the enclosed arm
continuously for 300 s. Based on experiment 1, we observed that
the latencies to enter an open arm of the ETM apparatus increase
spontaneously within trials, thus suggesting inhibitory avoidance
acquisition. Additionally, we  found that mice learned a preference
for the enclosed arm of the ETM apparatus after successive expo-
sures, which was particularly evoked during the test session. In
fact, statistically signiﬁcant differences were detected between the
baseline latency and the latency to ﬁrst enter an open arm during
the test session.
In this study, we also investigated the effects of diazepam, a
benzodiazepine with anxiolytic and amnestic effects, and biperi-
den, a M1 muscarinic receptor antagonist with amnestic effects, on
mice with respect to the ETM task. First, we found that the anx-
iolytic effects of diazepam (at both doses tested) were detected
in the training session, when animals were injected pre-training.
These observations are in agreement with results that have been
previously reported for rats [14] and mice [7],  and validate that
the proposed ETM protocol is sensitive to the anxiolytic effects of
benzodiazepine drugs in mice.
Despite the anxiolytic effects of pre-training administration of
diazepam being detected at both doses tested, only at 2 mg/kg did
this drug signiﬁcantly reduce the latency to enter an open arm of the
am (B) to mice submitted to the ETM task. Latencies to enter one of the open arms
fter the training session. The animals were treated 30 min before the test session.
diazepam 1 mg/kg, DZP 2: diazepam 2 mg/kg.
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Fig. 5. Effects of the administration of 0.5 and 1 mg/kg biperiden (A and B) and 1 and 2 mg/kg diazepam (C and D) on the cumulative distance moved in the open ﬁeld test
recorded during 15 min  and over a consecutive 5 min. Data are shown as the mean ± S.E.M. (7–11 mice/group). ANOVA, Dunnett’s test; *P < 0.05 compared to vehicle. BPR
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h.5:  biperiden 0.5 mg/kg, BPR 1: biperiden 1 mg/kg, DZP 1: diazepam 1 mg/kg, DZP 
TM during the test session. This suggests an impairment of mem-
ry formation and/or storage, which is in agreement with previous
ndings in rats [8].  Our results also support the hypothesis that the
ffects of diazepam on anxiety and memory acquisition appear to
e unrelated and are dependent on the dose used. Additionally, no
lterations in spontaneous locomotor activity were detected in ani-
als treated with diazepam; this supports the genuine behavioral
esponse observed for diazepam on memory and anxiety in mice
ubjected to the ETM task.
Our ﬁndings also indicate that the pre-training administration
f 1 mg/kg biperiden increased the number of trials needed to reach
he avoidance criterion of staying 300 s in the enclosed arm, which
ould be interpreted as passive avoidance learning impairment.
n the test session, the pre-training administration of biperiden
educed the latency to enter an open arm compared to controls,
uggesting low memory retention. The present study also revealed
hat 1 mg/kg biperiden, administered 30 min  before testing signif-
cantly increased spontaneous locomotion in the open ﬁeld. These
lterations in locomotion caused by biperiden could bias learning
nd memory-related responses in the ETM task, especially when
nimals are under biperiden effects; this was the case when we
ssessed the action of biperiden when injected before training.
hus, we cannot rule out that the signiﬁcant increase in the number
f trials to reach the avoidance criterion displayed by biperiden-
reated mice could be due to the hyperlocomotion evoked by drug
dministration. A similar interpretation was proposed to explain
he ﬁndings reported by De-Mello and Carobrez [10] when they
howed that 1.2 mg/kg scopolamine increased the number of trials
eeded to reach the avoidance criterion in the ETM task and caused
yperlocomotion in the open ﬁeld [10].epam 2 mg/kg.
In the present study, we also showed that the post-training
administration of biperiden or diazepam did not affect mem-
ory consolidation assessed in the test session. Well documented
anterograde amnesia has been widely reported for benzodi-
azepines. However, when injected post-training, benzodiazepines
evoke opposite effects on memory, depending on the animal model
being studied. In fact, benzodiazepines do not affect spatial mem-
ory consolidation when tested using the water maze task [4,23],
but impair aversive memory retention when using the one-trial
inhibitory avoidance, an animal model of conditioned aversive
memory [16,31]. This suggests that the ETM task could be modulat-
ing a type of memory which involves distinct neuronal pathways
from that activated by conditioned aversive memories.
Considering the relevant role played by cholinergic signaling
in memory consolidation in the hippocampus, aversive memory
was  affected by the muscarinic antagonist scopolamine when post-
training injected at doses higher than 1 mg/kg in mice [12,26,27].
Regarding non-aversive memories, very few studies have evalu-
ated the effects of muscarinic antagonists injected post-training. It
seems that working and spatial memory acquired using long train-
ing sessions are relatively resistant to cholinergic blockade [3,5].
This is likely the explanation for the lack of memory modulation
when biperiden was injected post-training. Our training session
depended on mice reaching the avoidance criterion, and this could
happen after 10–15 min  (or more) for each animal. During this
period mice are therefore spatially and contextually constructing
a strategy to cope with the aversive situation, thus suggesting that
this strategy is quite resistant to cholinergic blockade (even 3 mg/kg
biperiden was not able to affect memory consolidation in the ETM
task).
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Our ﬁndings showed that the pre-test administration of biperi-
en or diazepam did not affect memory retrieval in the ETM task.
o our knowledge, few studies have assessed the effects of drugs
n memory retrieval when they are pre-test injected. In the mouse
assive avoidance task, 3 mg/kg pre-test injected scopolamine, a
onselective muscarinic antagonist, signiﬁcantly affected memory
etrieval [27]. It should be noted, however, that scopolamine at
his dose could cause signiﬁcant peripheral effects (pupil dilata-
ion), despite hyperlocomotion and attention deﬁcits, which could
ias behavior assessment (for a review see [18]). Nevertheless, in
he present study we used biperiden, which has been proposed
s a more selective compound in comparison to scopolamine to
nduce cholinergic mnemonic deﬁcits in rodents [19] as the amnes-
ic agent. Our ﬁndings reinforce the view that the pre-test blockade
f cholinergic receptors does not affect memory retrieval in the ETM
ask.
The ETM task seems to be a procedure based on the avoidance
f open arms learned during the training session [33]; when mice
re re-exposed to the ETM apparatus after 24 h (or even 48 or 96 h
r 15 days), they display increased latency to enter in an open arm,
hus suggesting long-term memory retention. Most likely during
he training session (within trials), animals learn to discriminate
etween the open and enclosed arms of the apparatus, and then
uring the test session, they express their choice based on previous
xperience. This hypothesis could be supported by previous obser-
ations reported by File [11], which showed that benzodiazepines
id not promote anxiolytic-like effects in rats previously exposed
o the elevated plus-maze test. This effect was named “one-trial tol-
rance”, and for several years, authors proposed that distinct types
f anxiety were the basis of these two explanations of the appara-
us (for a review see [11,25]). However, a primary example of this
henomenon was found in the control animals, which displayed
educed exploration of the open arms during the second exposure
o the apparatus compared to the ﬁrst. Some authors proposed an
nvolvement of a mnemonic process in the mediation of this phe-
omenon [2,20].  Interestingly, Bertoglio and Carobrez [1] reported
hat administration of scopolamine before the ﬁrst exposition to the
levated plus maze prevented the “one-trial tolerance” observed
uring the animals’ second exposure. More recently, Gazarini et al.
13] showed that the administration of a protein synthesis inhibitor
anisomycin) into the hippocampus blocked “one-trial tolerance”
o benzodiazepines in rats and partially restored the control base-
ine exploration of open arms. Taken together, these ﬁndings are
n agreement with the idea that the memory process possibly
nderlies the behavior observed during re-exposure to the elevated
lus-maze test, thus reinforcing the view that the re-exposure to
he ETM task involves a memory process. However, further stud-
es that investigate biochemical and neuronal pathways involved
n these behaviors assessed via the ETM task are needed.
. Conclusions
In conclusion, the present study pharmacologically validates the
TM task as a model for the investigation of anxiety and memory
imultaneously in mice. The effects on anxiety were able to be esti-
ated in the training session as shown by the reduction of latency
o enter one of the ETM open arms with all four paws in the ﬁrst
hree consecutive trials. In addition, memory can be assessed in the
est session by recording the latency to enter the open arm dur-
ng re-exposure. Diazepam and biperiden (each at higher doses)
mpaired memory acquisition when injected pre-training, while
hese drugs did not affect memory consolidation and retrieval when
njected post-training or prior to testing. Finally, further studies
iming to evaluate the effects of other drugs on anxiety and mem-
ry systems in the mouse ETM task are in progress by our research
roup.
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